Four randomized trials show mixed results for substance-use therapies

The Effectiveness of Psychotherapy-Based Interventions in Individuals with Substance Use Disorders: A Systematic Review.

Substance use & misuse • • Relevant
🤖

AI Summary

This systematic review asked whether psychotherapy-based interventions reduce non-alcohol substance use among people with diagnosed substance use disorders. It synthesized randomized controlled trials published from 2022 to 2025, including studies of integrated motivational interviewing and cognitive behavioral therapy (CBT), cannabis-focused CBT, acceptance and commitment therapy combined with contingency management, and a brief family intervention. The review used PRISMA, RoB 2, and GRADE methods and reported findings narratively.

Substance-use outcomes favored the intervention in two trials, were inconclusive in one, and showed no significant difference in another. Psychological, functional, and treatment-engagement findings were mixed. The four trials were heterogeneous, and certainty was low or very low across the reported substance-use comparisons; this abstract-based summary cannot establish which intervention works best or which recovery domains benefit most. The authors call for larger trials with prespecified analyses and sustained follow-up.

💡 Key Findings

1
Across the four trials, substance-use findings favored interventions in two, were inconclusive in one, and showed no significant difference in another.
High
95%
2
Psychological, functional, and treatment-engagement outcomes were mixed across the reviewed trials.
High
90%
3
Certainty for substance-use comparisons was low or very low, limiting conclusions about which interventions or recovery domains benefit most.
High
95%

📄 Original Abstract

BACKGROUND: Psychotherapy-based interventions for non-alcohol substance use disorders (SUDs) have been evaluated across different populations and outcome domains. This review synthesized randomized evidence published between 2022 and 2025 and assessed its risk of bias and certainty. METHODS: The review followed PRISMA 2020 and was registered in PROSPERO (CRD420261304767). PubMed, PsycINFO, Web of Science, and Scopus were searched for studies published between January 2022 and December 2025. Eligible studies were primary reports of efficacy-focused randomized controlled trials involving participants with diagnosed non-alcohol SUDs and reporting at least one actual substance-use outcome. Alcohol-only studies, pilot/feasibility trials, secondary analyses, and mechanism-focused reports were excluded. Risk of bias was assessed using RoB 2 and certainty using GRADE. Findings were synthesized narratively. Eligibility criteria were narrowed during peer review. RESULTS: Four trials evaluated integrated motivational interviewing and cognitive behavioral therapy (CBT), cannabis-focused CBT, acceptance and commitment therapy combined with contingency management, and a brief family intervention. Between-group substance-use findings favored the interventions in two trials, were inconclusive in one, and showed no significant difference in another. Psychological, functional, and treatment-engagement findings were mixed. Two assessed substance-use results were judged at high risk of bias, and two raised some concerns. Certainty was low for two substance-use comparisons and very low for two, reflecting risk of bias and imprecision. CONCLUSIONS: The four heterogeneous trials provided mixed evidence on substance-use and psychosocial outcomes. Low to very low certainty precludes conclusions about which interventions or recovery domains benefit most. Larger trials with prespecified analyses and sustained follow-up are needed.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.